March 13, 2026 10:45 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Nobody will hire them': Supreme Court says menstrual leave would backfire, hurt women's careers | Rupee sinks to record low as West Asia conflict shakes Indian markets | ₹20 lakh crore wiped out: Indian markets post worst week in 4 years amid West Asia tensions | America’s flip-flop on Russian oil: How Washington sends conflicting signals to India | Big diplomatic win! Iran allows Indian oil tankers through the Strait of Hormuz | ‘It was over in the first hour’: Trump declares victory in Iran war, says ‘nothing left to target’ | Indian-origin shopkeepers face targeted attacks in Wembley; Somali men suspected | Iran pulls out of 2026 FIFA World Cup amid war with US-Israel | Supreme Court allows first-ever passive euthanasia for 32-year-old man in coma for 13 years | As Iran-US war disrupts global gas supply, India issues guidelines to manage shortages
IndiaFightsCorona
Image credit: UNI

India records 4.03 lakh fresh Covid cases, 4,092 deaths in last 24 hours

| @indiablooms | May 09, 2021, at 04:27 pm

New Delhi/IBNS: India recorded 4,03,738 fresh Covid cases and 4,092 deaths in the last 24 hours, the Union Health Ministry said on Sunday.

The fresh infections have pushed the overall case count to 2.22 crore.

The country has been witnessing over 4 lakh daily infections for the fifth time in a week and over 4,000 deaths for the second straight day.

Meanwhile, the Supreme Court on Saturday constituted a twelve-member National Task Force (NTF) to streamline the scientific allocation of Liquid Medical Oxygen across the country to deal with the shortage of life-saving gas amid virulent second wave of COVID-19 pandemic.

A bench of Justices DY Chandrachud and MR Shah asserted that the task force has medical experts and doctors from across the country as its members and will have the Cabinet Secretary to the central government as its convenor.

To combat the crisis, the Drug Controller General of India (DCGI) has approved the emergency use of DRDO's anti-COVID-19 therapeutic oral drug 2-deoxy-D-glucose (2-DG) as an adjunct therapy in moderation to severe COVID-19 patients.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.